Products

Peripheral Neuropathy Management Peripheral neuropathy is a condition caused by damage to the peripheral nerves, leading to symptoms such as numbness, tingling, burning pain, weakness, or loss of sensation—most commonly in the hands and feet. Effective management focuses on identifying the underlying cause, relieving symptoms, and preventing further nerve damage. Causes of Peripheral Neuropathy Diabetes (most common cause) Vitamin deficiencies (especially B12) Infections and autoimmune disorders Toxins, alcohol, and certain medications Genetic and metabolic conditions

Neuromuscular disorders are a group of conditions that affect the nerves controlling voluntary muscles, the muscles themselves, or the connection between nerves and muscles. These disorders can lead to muscle weakness, fatigue, cramps, and loss of muscle function, significantly impacting daily activities and quality of life. Types of Neuromuscular Disorders Peripheral neuropathies – Damage to peripheral nerves (e.g., diabetic neuropathy) Motor neuron diseases – Such as amyotrophic lateral sclerosis (ALS) Muscle disorders (myopathies) – Including muscular dystrophies and inflammatory myopathies Neuromuscular junction disorders – Such as myasthenia gravis Inherited neuromuscular diseases – Genetic conditions affecting nerves or muscles Causes Neuromuscular disorders may be caused by: Genetic abnormalities Autoimmune diseases Metabolic and endocrine disorders Infections or toxins Medications and systemic illnesses

Parkinson’s disease is a progressive neurological movement disorder that primarily affects movement control. It occurs due to the gradual loss of dopamine-producing nerve cells in a specific area of the brain, leading to characteristic motor and non-motor symptoms. Key Symptoms Parkinson’s disease typically presents with a combination of the following: Tremor at rest, often starting in one hand Bradykinesia (slowness of movement) Muscle rigidity Postural instability and balance problems In addition to movement-related symptoms, patients may experience non-motor symptoms such as sleep disturbances, constipation, mood changes, memory problems, and reduced sense of smell. Causes and Risk Factors The exact cause of Parkinson’s disease is unknown. Factors that may contribute include genetic susceptibility, environmental exposures, and aging.

Epilepsy management is a comprehensive, long-term approach aimed at controlling seizures, minimizing side effects, and improving the overall quality of life for individuals living with epilepsy. Effective management requires accurate diagnosis, individualized treatment, and regular follow-up under the care of a neurologist. Accurate Diagnosis Proper epilepsy management begins with confirming the diagnosis and identifying the seizure type and epilepsy syndrome. This involves: Detailed medical history and seizure description Neurological examination EEG and video EEG monitoring Brain imaging (MRI) to detect structural causes Medical Treatment Anti-seizure medications (ASMs) are the mainstay of epilepsy treatment. The choice of medication depends on seizure type, age, comorbid conditions, and lifestyle factors. The goal is to achieve complete seizure control with minimal side effects.

Neuroimaging interpretation is the expert analysis of brain and spinal cord images to diagnose, monitor, and manage neurological disorders. It involves correlating imaging findings with clinical symptoms to provide accurate, meaningful conclusions that guide patient care. Common Neuroimaging Modalities Magnetic Resonance Imaging (MRI) – Provides detailed images of brain and spinal cord structures; essential for detecting tumors, stroke, multiple sclerosis, and inflammatory conditions Computed Tomography (CT) – Rapid imaging useful in emergencies such as acute stroke, head injury, and intracranial bleeding CT/MR Angiography – Visualizes blood vessels to identify aneurysms, stenosis, or vascular malformations Functional MRI (fMRI) – Assesses brain activity and functional areas Diffusion-weighted imaging (DWI) – Critical for early detection of acute ischemic stroke

Nerve Conduction Studies (NCS) are diagnostic tests used to evaluate how well and how fast electrical signals travel through peripheral nerves. They are a key component of electrodiagnostic testing and are commonly performed alongside Electromyography (EMG) to assess nerve function accurately. Purpose of NCS NCS help determine whether symptoms such as numbness, tingling, pain, or weakness are caused by nerve damage, nerve compression, or disease affecting the peripheral nervous system. How NCS Are Performed During the test, small surface electrodes are placed on the skin over specific nerves and muscles. A mild electrical stimulus is applied to the nerve, and the resulting electrical response is recorded. The test measures nerve conduction speed, amplitude, and latency, which indicate nerve health.

Clinical trials participation guidance helps patients and caregivers understand, evaluate, and navigate opportunities to take part in clinical research studies. In neurology, clinical trials play a crucial role in advancing new treatments, improving existing therapies, and enhancing understanding of neurological diseases. Purpose of Participation Guidance The goal is to provide clear, unbiased information so patients can make informed decisions about whether joining a clinical trial is appropriate for their condition and personal circumstances. What Clinical Trials Involve Clinical trials are carefully designed research studies that may include: New medications or biologic therapies Innovative medical devices Advanced rehabilitation techniques Novel diagnostic or preventive strategies

Neurorehabilitation coordination is a structured, patient-centered approach that ensures seamless planning, delivery, and monitoring of rehabilitation services for individuals with neurological disorders or injuries. It focuses on integrating multiple therapies to maximize recovery, restore function, and improve quality of life. Purpose of Neurorehabilitation Coordination The goal is to provide continuous and organized care from the acute phase through long-term recovery. Proper coordination helps avoid delays, duplication of services, and gaps in treatment. Who Needs Neurorehabilitation? Neurorehabilitation is beneficial for patients recovering from: Stroke Traumatic brain injury Spinal cord injury Multiple sclerosis Parkinson’s disease and movement disorders Neuromuscular disorders

Multiple Sclerosis (MS) is a chronic autoimmune neurological disorder in which the body’s immune system attacks the protective myelin sheath covering nerve fibers in the brain and spinal cord. Comprehensive MS care focuses on early diagnosis, effective disease control, symptom management, and long-term support to help patients maintain independence and quality of life. Early Diagnosis and Evaluation Accurate and early diagnosis is essential for effective MS management. Evaluation includes: Detailed neurological examination MRI of the brain and spinal cord to detect demyelinating lesions Evoked potential studies to assess nerve pathway function Cerebrospinal fluid (CSF) analysis in selected cases Disease-Modifying Therapy (DMT) Disease-modifying treatments are the cornerstone of MS care. These therapies help: Reduce relapse frequency Slow disease progression Minimize new lesion formation

Tremors are involuntary, rhythmic shaking movements that commonly affect the hands but can also involve the head, voice, legs, or trunk. They are one of the most frequent movement-related neurological symptoms and can range from mild and occasional to severe and disabling. Types of Tremors Resting tremor – Occurs when the affected body part is at rest; commonly seen in Parkinson’s disease Action tremor – Occurs during voluntary movement Postural tremor – While holding a position against gravity Kinetic tremor – During movement Essential tremor – The most common tremor disorder, often hereditary Intention tremor – Worsens as the limb approaches a target, usually due to cerebellar disease Causes of Tremors Tremors may be caused by: Parkinson’s disease and other movement disorders Essential tremor Stroke or brain injury Multiple sclerosis Thyroid disorders and metabolic imbalances Medications, caffeine, or stress Symptoms Shaking of hands, head, or voice Difficulty with fine motor tasks such as writing or eating Tremor that worsens with stress, fatigue, or anxiety Improvement or worsening with specific activities

Movement disorders are neurological conditions that affect the speed, fluency, quality, and control of voluntary and involuntary movements. They may cause excessive movements, slowed movements, abnormal postures, or difficulty initiating movement, significantly impacting daily activities and quality of life. Types of Movement Disorders Parkinson’s disease and parkinsonism – Characterized by slowness, stiffness, tremor, and balance problems Tremor disorders – Including essential tremor and other action or resting tremors Dystonia – Sustained or intermittent muscle contractions causing abnormal postures or movements Chorea and athetosis – Irregular, flowing, involuntary movements Myoclonus – Sudden, brief muscle jerks Tics and Tourette syndrome – Repetitive, involuntary movements or vocalizations

Neurogenetic counseling is a specialized medical service that helps individuals and families understand the genetic basis of neurological disorders. It combines neurology and genetics to assess inherited conditions affecting the brain, spinal cord, nerves, and muscles, and provides guidance on diagnosis, risk assessment, and future planning. Purpose of Neurogenetic Counseling The primary goal is to explain how genetic factors contribute to neurological diseases, clarify inheritance patterns, and support patients in making informed medical and personal decisions. Conditions Addressed Neurogenetic counseling is useful for conditions such as: Hereditary movement disorders (e.g., Huntington’s disease, inherited dystonias) Genetic epilepsies Neuromuscular disorders (muscular dystrophies, spinal muscular atrophy) Inherited neuropathies (Charcot–Marie–Tooth disease) Neurodegenerative disorders with genetic components